286992
Hospitalization for bicycle-related injuries in Taiwan
Methods: This secondary data analysis was a retrospective cross sectional study. Data came from the 2007 hospitalization claims in National Health Insurance data set. Study samples were identified as those hospitalizations with ICD9-CM external cause of injury codes related to bicycle-related injuries. We hypothesized that the number of hospitalization, the length of stays (LOS), and medical expenditures vary by patients' gender, age, injury type, and collision with vehicles. We took log transformation of LOS and expenditures to adjust for the skewed nature before analyzing multiple linear regression. Results: In terms of diagnoses of injury, fracture ranked the first (47.1%), followed by TBI (33.8%). Regarding the types of traffic accident, most of the hospitalizations (74.6%) were collisions with vehicles involving cars or motorcycles. Patients who aged more than 65 years old, and waived copayment had significantly longer LOS (p<0.05). Conclusions: We found that the hospitalizations distribution of bicycle-related injuries differed from patients' demographic characteristics. This finding can be used to promote bicycle safety on preventing injuries through different stakeholders such as health, or transportation, and local governments.
Planning of health education strategies, interventions, and programs
Public health administration or related administration
Public health or related public policy
Public health or related research
Social and behavioral sciences
Learning Objectives:
Describe bicycle-related injury hospitalizations in Taiwan
Keywords: Injury, Health Care Utilization
Qualified on the content I am responsible for because: I have been accepted the National Science Council funded grants focusing on the health care utilization and economic evaluation. Among my scientific interests were public health and health care utilization.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.